Cargando…

Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis

Patients with cirrhosis are known to have multiple comorbidities and impaired organ system functioning due to alterations caused by chronic liver failure. In the past two years, since the COVID-19 pandemic started, several studies have described the affinity of SARS-CoV-2 with the liver and biliary...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerbu, Bianca, Grigoras, Mirela Loredana, Bratosin, Felix, Bogdan, Iulia, Citu, Cosmin, Bota, Adrian Vasile, Timircan, Madalina, Bratu, Melania Lavinia, Levai, Mihaela Codrina, Marincu, Iosif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836842/
https://www.ncbi.nlm.nih.gov/pubmed/35160114
http://dx.doi.org/10.3390/jcm11030652
_version_ 1784649777228546048
author Cerbu, Bianca
Grigoras, Mirela Loredana
Bratosin, Felix
Bogdan, Iulia
Citu, Cosmin
Bota, Adrian Vasile
Timircan, Madalina
Bratu, Melania Lavinia
Levai, Mihaela Codrina
Marincu, Iosif
author_facet Cerbu, Bianca
Grigoras, Mirela Loredana
Bratosin, Felix
Bogdan, Iulia
Citu, Cosmin
Bota, Adrian Vasile
Timircan, Madalina
Bratu, Melania Lavinia
Levai, Mihaela Codrina
Marincu, Iosif
author_sort Cerbu, Bianca
collection PubMed
description Patients with cirrhosis are known to have multiple comorbidities and impaired organ system functioning due to alterations caused by chronic liver failure. In the past two years, since the COVID-19 pandemic started, several studies have described the affinity of SARS-CoV-2 with the liver and biliary cells. Considering hepatitis C as a significant independent factor for cirrhosis in Romania, this research was built on the premises that this certain group of patients is susceptible to alterations of their serum parameters that are yet to be described, which might be useful in the management of COVID-19 in these individuals. A retrospective cohort study was developed at a tertiary hospital for infectious disease in Romania, which included a total of 242 patients with hepatitis C cirrhosis across two years, out of which 46 patients were infected with SARS-CoV-2. Stratification by patient weight and COVID-19 status identified several important laboratory serum tests as predictors for acute-on-chronic liver failure and risk for intensive care unit admission. Thus, white blood cell count, lymphocyte count, ferritin, hypoglycemia, prothrombin time, and HCV viral load were independent risk factors for ACLF in patients with COVID-19. High PT, creatinine, BUN, and HCV viral load were the strongest predictors for ICU admission. Inflammatory markers and parameters of gas exchange were also observed as risk factors for ACLF and ICU admission, including procalcitonin, CRP, IL-6, and D-dimers. Our study questions and confirms the health impact of COVID-19 on patients with cirrhosis and whether their laboratory profile significantly changes due to SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-8836842
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88368422022-02-12 Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis Cerbu, Bianca Grigoras, Mirela Loredana Bratosin, Felix Bogdan, Iulia Citu, Cosmin Bota, Adrian Vasile Timircan, Madalina Bratu, Melania Lavinia Levai, Mihaela Codrina Marincu, Iosif J Clin Med Article Patients with cirrhosis are known to have multiple comorbidities and impaired organ system functioning due to alterations caused by chronic liver failure. In the past two years, since the COVID-19 pandemic started, several studies have described the affinity of SARS-CoV-2 with the liver and biliary cells. Considering hepatitis C as a significant independent factor for cirrhosis in Romania, this research was built on the premises that this certain group of patients is susceptible to alterations of their serum parameters that are yet to be described, which might be useful in the management of COVID-19 in these individuals. A retrospective cohort study was developed at a tertiary hospital for infectious disease in Romania, which included a total of 242 patients with hepatitis C cirrhosis across two years, out of which 46 patients were infected with SARS-CoV-2. Stratification by patient weight and COVID-19 status identified several important laboratory serum tests as predictors for acute-on-chronic liver failure and risk for intensive care unit admission. Thus, white blood cell count, lymphocyte count, ferritin, hypoglycemia, prothrombin time, and HCV viral load were independent risk factors for ACLF in patients with COVID-19. High PT, creatinine, BUN, and HCV viral load were the strongest predictors for ICU admission. Inflammatory markers and parameters of gas exchange were also observed as risk factors for ACLF and ICU admission, including procalcitonin, CRP, IL-6, and D-dimers. Our study questions and confirms the health impact of COVID-19 on patients with cirrhosis and whether their laboratory profile significantly changes due to SARS-CoV-2 infection. MDPI 2022-01-27 /pmc/articles/PMC8836842/ /pubmed/35160114 http://dx.doi.org/10.3390/jcm11030652 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cerbu, Bianca
Grigoras, Mirela Loredana
Bratosin, Felix
Bogdan, Iulia
Citu, Cosmin
Bota, Adrian Vasile
Timircan, Madalina
Bratu, Melania Lavinia
Levai, Mihaela Codrina
Marincu, Iosif
Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis
title Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis
title_full Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis
title_fullStr Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis
title_full_unstemmed Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis
title_short Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis
title_sort laboratory profile of covid-19 patients with hepatitis c-related liver cirrhosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836842/
https://www.ncbi.nlm.nih.gov/pubmed/35160114
http://dx.doi.org/10.3390/jcm11030652
work_keys_str_mv AT cerbubianca laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT grigorasmirelaloredana laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT bratosinfelix laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT bogdaniulia laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT citucosmin laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT botaadrianvasile laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT timircanmadalina laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT bratumelanialavinia laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT levaimihaelacodrina laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis
AT marincuiosif laboratoryprofileofcovid19patientswithhepatitiscrelatedlivercirrhosis